Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma
RALEIGH, N.C., June 20, 2011 /PRNewswire/ -- Pharmaceutical Institute, the leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, announced today the completion of 2011 updates to its Therapeutic Area Essentials™ e-course series. This series delivers in-depth disease state training for pharmaceutical and biotech R&D and commercial professionals. It includes 155 e-courses covering the diagnosis, cause, and treatment for more than 45 disease states.
Therapeutic Area Essentials™ provides the pharmaceutical and biotech industry with a single source for current and comprehensive disease state training. All courses have been updated in 2011 by Pharmaceutical Institute's content scientists and physician experts. Updates reflect the most current disease state knowledge such as prevalence and incidence statistics, disease understanding (including cause, risk factors, and progression), diagnostic procedures, and treatment guidelines.
"Providing pharma and biotech employees with immediate, needs-based access to high quality disease state training can deliver significant value," says Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute. "We're pleased to provide a go-to resource for high-quality training content across the therapeutic area spectrum."
Core therapeutic areas covered by Therapeutic Area Essentials™ include cardiology and metabolic disorders, gastroenterology, infections, musculoskeletal, neurology, oncology, ophthalmology, and respiratory disorders. The series also provides anatomy and physiology training for each of these systems.